The Stock2Me Podcast

The Stock2Me Podcast

Innovative corporate communications and content distribution strategies

Episodes

July 13, 2022 19 min

Stock2Me’s latest podcast features two-time Olympic gold medalist Abby Wambach speaking on behalf of Odyssey Health Inc. (OTC: ODYY), a medical technology company developing a drug/device combination intended to treat concussion. Wambach is a member of Odyssey’s sports advisory board, which aims to support the company’s efforts to enhance public awareness of traumatic brain injuries and concussions, as well as the need for an FDA-a...

Share
Mark as Played

Stock2Me’s latest podcast features two-time Olympic gold medalist Abby Wambach speaking on behalf of Odyssey Health Inc. (OTC: ODYY), a medical technology company developing a drug/device combination intended to treat concussion. Wambach is a member of Odyssey’s sports advisory board, which aims to support the company’s efforts to enhance public awareness of traumatic brain injuries and concussions, as well as the need for an FDA-a...

Share
Mark as Played

Stock2Me’s latest podcast features the return of Ian Clifford, CEO of FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF), a growth stage company committed to providing commercially viable and sustainable “cradle to cradle” clean technology solutions, including green ammonia (NH3), for use across a broad spectrum of industries and applications. 

Throughout the interview, Clifford discussed FuelPositive’s rapid development throughout 20...

Share
Mark as Played

Stock2Me’s latest podcast features the return of Ian Clifford, CEO of FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF), a growth stage company committed to providing commercially viable and sustainable “cradle to cradle” clean technology solutions, including green ammonia (NH3), for use across a broad spectrum of industries and applications. 

Throughout the interview, Clifford discussed FuelPositive’s rapid development throughout 20...

Share
Mark as Played

Stock2Me’s latest podcast features Chris Bunka, Chairman & CEO of Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms.

To begin the interview, Bunka provided a summary of Lexaria’s business model, which is focused on leveraging the company’s proprietary DehydraTECH™ drug delivery technology.

“[Lexaria has] developed a drug delivery technology that’s quite unique,” Bunka said. “What our technol...

Share
Mark as Played

Stock2Me’s latest podcast features Chris Bunka, Chairman & CEO of Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms.

To begin the interview, Bunka provided a summary of Lexaria’s business model, which is focused on leveraging the company’s proprietary DehydraTECH™ drug delivery technology.

“[Lexaria has] developed a drug delivery technology that’s quite unique,” Bunka said. “What our technol...

Share
Mark as Played

Stock2Me’s latest podcast features Ian Clifford, CEO of FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF), a growth stage company focused on manufacturing, licensing, partnership and acquisition opportunities building upon various technological achievements.

Throughout the interview, Clifford discussed FuelPositive’s innovative carbon-free ammonia technology and its potential to change the energy landscape, both across Canada and aro...

Share
Mark as Played

Stock2Me’s latest podcast features Ian Clifford, CEO of FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF), a growth stage company focused on manufacturing, licensing, partnership and acquisition opportunities building upon various technological achievements.

Throughout the interview, Clifford discussed FuelPositive’s innovative carbon-free ammonia technology and its potential to change the energy landscape, both across Canada and aro...

Share
Mark as Played

Stock2Me’s latest podcast features Dr. Art Dawson, U.S. Business Manager of Save Foods (NASDAQ: SVFD), an agri-food tech company focused on developing and selling eco-friendly products specifically designed to ensure food safety and extend the shelf life of fresh fruits and vegetables.

Throughout the interview, Dawson discussed Save Foods’ innovative technology and examined how its products are helping combat excessive waste in the...

Share
Mark as Played

Stock2Me’s latest podcast features Dr. Art Dawson, U.S. Business Manager of Save Foods (NASDAQ: SVFD), an agri-food tech company focused on developing and selling eco-friendly products specifically designed to ensure food safety and extend the shelf life of fresh fruits and vegetables.

Throughout the interview, Dawson discussed Save Foods’ innovative technology and examined how its products are helping combat excessive waste in the...

Share
Mark as Played

Stock2Me’s latest podcast features Shan Sawant, Director of Communications for AmpliTech Group Inc. (NASDAQ: AMPG), a company engaged in the design, development and manufacture of custom radio frequency (RF) components for the commercial, SATCOM, space and military markets.

Throughout the interview, Sawant discussed AmpliTech’s business model, offering an overview of the company’s proven, decades-long track record of providing vita...

Share
Mark as Played

Stock2Me’s latest podcast features Shan Sawant, Director of Communications for AmpliTech Group Inc. (NASDAQ: AMPG), a company engaged in the design, development and manufacture of custom radio frequency (RF) components for the commercial, SATCOM, space and military markets.

Throughout the interview, Sawant discussed AmpliTech’s business model, offering an overview of the company’s proven, decades-long track record of providing vita...

Share
Mark as Played

Stock2Me’s latest podcast features Allan Jones, President of Emaginos Inc., which recently submitted a U.S. patent application for its EdManage analytics platform for public education.

Throughout the interview, Jones discussed how the EdManage program was developed, how it works and the benefits it provides for students.

“A few years ago, our Director of Education, Dr. Keith Larick, was school superintendent in Tracy, California. H...

Share
Mark as Played

Stock2Me’s latest podcast features Allan Jones, President of Emaginos Inc., which recently submitted a U.S. patent application for its EdManage analytics platform for public education.

Throughout the interview, Jones discussed how the EdManage program was developed, how it works and the benefits it provides for students.

“A few years ago, our Director of Education, Dr. Keith Larick, was school superintendent in Tracy, California. H...

Share
Mark as Played

Stock2Me’s latest podcast features Greg McKee, Chairman and CEO of Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing treatments, primarily psychedelics like psilocybin, for diseases with unmet medical needs.

Throughout the interview, McKee discussed the company’s prospective patients and targeted ailments, the need for innovation in the psychedelics space and Tryp’s planned human clin...

Share
Mark as Played

Stock2Me’s latest podcast features Greg McKee, Chairman and CEO of Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing treatments, primarily psychedelics like psilocybin, for diseases with unmet medical needs.

Throughout the interview, McKee discussed the company’s prospective patients and targeted ailments, the need for innovation in the psychedelics space and Tryp’s planned human clin...

Share
Mark as Played

Stock2Me’s latest podcast features Scott Shellady, a financial markets commentator who can frequently be seen on Fox Business, Bloomberg, CNN and TD Ameritrade.

During the interview, Shellady provided a brief overview of his background, his outlook on the trends guiding the market in 2021 and the importance of the next 18 months as the economy continues to get up-to-speed in the wake of the global pandemic.

“I’ve been in the financ...

Share
Mark as Played

Stock2Me’s latest podcast features Brent Bedford, President, Chairman & CEO of Perpetual Industries Inc. (OTC: PRPI).

During the interview, Bedford provided an introduction to Perpetual Industries’ business model and how the company is working to minimize the hurdles that can stand in the way of innovation.

“Perpetual Industries really came out of an idea of innovation, helping all these great minds that we have in the world co...

Share
Mark as Played

Stock2Me’s latest podcast features Brent Bedford, President, Chairman & CEO of Perpetual Industries Inc. (OTC: PRPI).

During the interview, Bedford provided an introduction to Perpetual Industries’ business model and how the company is working to minimize the hurdles that can stand in the way of innovation.

“Perpetual Industries really came out of an idea of innovation, helping all these great minds that we have in the world co...

Share
Mark as Played

Stock2Me’s latest podcast features Brendan Cahill, President & CEO of Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2).

During the interview, Cahill provided an introduction to Excellon’s business model and its current portfolio of production and exploration resource projects spanning North America and Europe.

“Excellon’s actually been around quite a long time. It was founded in 1989 but got to Mexico in the ...

Share
Mark as Played

Popular Podcasts

    Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.

    Crime Junkie

    If you can never get enough true crime... Congratulations, you’ve found your people.

    Stuff You Should Know

    If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks then look no further. Josh and Chuck have you covered.

    The Daily

    This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro. Twenty minutes a day, five days a week, ready by 6 a.m.

    The Bobby Bones Show

    Listen to 'The Bobby Bones Show' by downloading the daily full replay.

Advertise With Us

For You

    Music, radio and podcasts, all free. Listen online or download the iHeart App.

    Connect

    © 2022 iHeartMedia, Inc.